FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.7  |  FHIR Version n/a  User: [n/a]

1367891007: Substance with neonatal fragment crystallizable receptor antagonist mechanism of action (substance)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Jul 2025. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
5465339018 Substance with neonatal fragment crystallizable receptor antagonist mechanism of action (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
5465340016 Neonatal Fc (fragment crystallizable) receptor antagonist en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
5469769015 Neonatal Fc (fragment crystallisable) receptor antagonist en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core


1 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Substance with neonatal fragment crystallizable receptor antagonist mechanism of action (substance) Is a Substance with receptor antagonist mechanism of action (substance) true Inferred relationship Some
Substance with neonatal fragment crystallizable receptor antagonist mechanism of action (substance) Has disposition (attribute) Neonatal Fc (fragment crystallizable) receptor antagonist true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Efgartigimod alfa Is a True Substance with neonatal fragment crystallizable receptor antagonist mechanism of action (substance) Inferred relationship Some

This concept is not in any reference sets

Back to Start